MedPath

Comparison of two drugs for Preterm Labor

Phase 2
Conditions
preterm labor.
Preterm labour and delivery
Registration Number
IRCT201012155401N1
Lead Sponsor
Hamadan university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
100
Inclusion Criteria

all high risk women for pre-term labour including: recurrent abortion, pre tem labour history, cervical rippening, etc. Exclusion criteria: Epileptic and asthmatic subjects; those with uncontrolled diabetes; those who were sensitive to progesterone; those who have received progesterone four weeks before the study; mental illness; chronic HTN; active liver disorder; HIV infection or 35> CD4 count and anti-viral drug recipients; placenta previa; history of genital and breast cancer; history of thromboembolic disease and mullerian anomaly; ultrasound diagnosed major anomaly; recognized fetal chromosomal abnormalities; Multiple cerclage and preterm labor and PROM and clinical chorioamnionitis; vaginal bleeding and history of spontaneous preterm labor without delivery (including preterm labor).

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Preterm labor. Timepoint: monthly. Method of measurement: questionnaire and physical exam.
Secondary Outcome Measures
NameTimeMethod
Delivery type. Timepoint: monthly. Method of measurement: questionnaire.
© Copyright 2025. All Rights Reserved by MedPath